Dnm1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
| Dynamin 1 |
|---|
| Gene Symbol | DNM1 |
| Full Name | Dynamin 1 |
| Chromosomal Location | 12p11.21 |
| NCBI Gene ID | [1756](https://www.ncbi.nlm.nih.gov/gene/1756) |
| OMIM | 602377 |
| Ensembl ID | ENSG00000106976 |
| UniProt ID | [Q05193](https://www.uniprot.org/uniprot/Q05193) |
| Associated Diseases | Epilepsy, Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Alzheimer's Disease |
DNM1 encodes Dynamin 1, a large GTPase essential for synaptic vesicle endocytosis. Dynamin 1 is specifically expressed in neurons and plays a critical role in clathrin-mediated synaptic vesicle recycling, making it fundamental to maintaining synaptic function. As a member of the dynamin family (DNM1, DNM2, DNM3), dynamin 1 mediates the final step of membrane fission during endocytosis, enabling synaptic vesicles to be recycled for subsequent rounds of neurotransmitter release.
- Chromosomal location: 12p11.21
- Genomic size: ~20 kb
- Exons: 22 exons
- Promoter: Neuron-specific expression elements
¶ Domain Organization
Dynamin 1 is a ~864 amino acid protein with distinct functional domains:
| Domain |
Position |
Function |
| N-terminal GTPase |
1-300 |
Catalyzes GTP hydrolysis |
| Middle domain |
300-500 |
Protein-protein interactions |
| PH domain |
500-650 |
Membrane binding |
| GTPase effector |
650-750 |
Oligomer assembly |
| C-terminal proline-rich |
750-864 |
Interactions with SH3 domains |
- Vesicle scission: Polymerizes around vesicle neck
- GTP hydrolysis: Conformational changes drive membrane fission
- Regulation: Phosphorylation/dephosphorylation controls activity
- Phosphorylation: Multiple serine/threonine sites
- Ubiquitination: Regulates protein stability
- SUMOylation: Alters subcellular localization
Dynamin 1 is essential for neuronal function:
- Clathrin coat assembly: Initiates vesicle formation
- Neck constriction: Polymerizes around vesicle neck
- Membrane fission: GTP hydrolysis drives scission
- Vesicle release: Coordinated with actin dynamics
- GTP binding: Induces conformational change
- Oligomerization: Forms helical spirals
- GTP hydrolysis: Powers conformational constriction
- Product release: GDP-bound form dissociates
- Clathrin: Coat component
- Amphiphysin: BAR domain scaffold
- Endophilins: Curvature-inducing proteins
- Dynamitin: Regulates dynactin complex
- Brain: Neuron-specific, very high expression
- Other tissues: Minimal expression
| Region |
Expression Level |
Cellular Localization |
| Hippocampus |
Very High |
All neuronal types |
| Cerebral Cortex |
Very High |
Pyramidal cells, interneurons |
| Basal Ganglia |
High |
Medium spiny neurons |
| Cerebellum |
High |
Purkinje cells, granule cells |
| Brainstem |
Moderate |
Motor and sensory neurons |
DNM1 mutations cause early-onset epileptic encephalopathy:
- Inheritance: Autosomal dominant, de novo
- Phenotype: Infantile seizures, developmental delay
- Mechanism: Gain-of-function enhances vesicle dynamics
- Treatment: Anti-seizure medications, ketogenic diet
- Pathology: Altered expression in AD brain
- Mechanism: Impaired synaptic vesicle recycling
- Aβ interaction: Colocalization with plaques
- Therapeutic target: Modulators in development
- Risk variants: GWAS-identified DNM1 variants
- Dopaminergic neurons: Enhanced vulnerability
- Synaptic dysfunction: Contributes to degeneration
- Mutant HTT: Interferes with DNM1 function
- Synaptic pathology: Impaired vesicle recycling
- Therapeutic implications: Restoration strategies
- Dynamin inhibitors: Target membrane fission
- GTPase modulators: Modify activity
- Kinase inhibitors: Control phosphorylation
- AAV-mediated DNM1 delivery approaches
- Viral vector targeting strategies
- Structural studies: High-resolution structures
- Therapeutic development: Brain-penetrant inhibitors
- Genetics: Variant pathogenicity
- Biomarkers: Synaptic dysfunction markers
- Animal models: Knockout and transgenic
- Dnm1 knockout: Fatal shortly after birth
- Conditional knockouts: Reveal essential neuronal role
- Transgenic: Disease-associated variants
The study of Dnm1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.